Marc Thibonnier

Step away from the slide decks and join informal, peer-led discussion groups. Share experiences, debate novel methodologies, and benchmark strategies with your peers in an intimate, high-value networking environment.

• Evaluating which disease drivers remain insufficiently addressed by current therapies to identify future opportunities for innovation and improve long-term patient outcomes
• Assessing emerging therapeutic mechanisms and combination approaches that may complement existing standards of care, enabling greater differentiation and expanding treatment options
• Discussing the characteristics that will define future best-in-class therapies, improving development prioritization and supporting long-term commercial and clinical success